C. Casat

发表

Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.

J. McGough, T. Wilens, L. Greenhill, 2006, Archives of pediatrics & adolescent medicine.

Replay: APPETITE AND WEIGHT IN CHILDREN TREATED FOR ADHD

C. Casat, William Hartnagel, 1999 .

Efficacy and safety of atomoxetine in childhood Attention-Deficit/Hyperactivity Disorder with comorbid Oppositional Defiant Disorder

S. West, J. Wernicke, R. Dittmann, 2004, Journal of attention disorders.

The dexamethasone suppression test in children and adolescents with major depressive disorder: a review.

C. Casat, K. Powell, 1988, The Journal of clinical psychiatry.

Treatment for Adolescents with Depression Study (TADS): safety results.

P. Rohde, B. Vitiello, S. McNulty, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders.

D. Lane, K. Loveland, D. Pearson, 2012, Journal of child and adolescent psychopharmacology.

Anxiety and depression in children and adolescents: Negative affectivity or separate constructs?

J. Lipovsky, A. Finch, C. Casat, 1989 .

A double-blind trial of bupropion in children with attention deficit disorder.

C. Casat, J. Van Wyck Fleet, D. Pleasants, 1987, Psychopharmacology bulletin.

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

K. Schuh, D. Coury, A. Allen, 2004, Pediatrics.

Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).

P. Rohde, A. Simons, B. Vitiello, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

The under- and over-diagnosis of mania in children and adolescents.

C. Casat, 1982, Comprehensive psychiatry.

Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial

J. Davidson, K. Connor, R. Weisler, 2003, Biological Psychiatry.

Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study

S. West, J. Wernicke, F. Sallee, 2002 .

Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

D. Lane, K. Loveland, D. Pearson, 2020, Journal of child and adolescent psychopharmacology.

Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.

D. Lane, K. Loveland, D. Pearson, 2013, Journal of child and adolescent psychopharmacology.

Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods.

Golda S. Ginsburg, B. Leventhal, G. Koch, 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD.

D. Lane, K. Loveland, D. Pearson, 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

Rodney J. Moore, J. Newcorn, C. Kratochvil, 2008, The American journal of psychiatry.

Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment.

T. Spencer, J. Newcorn, D. Geller, 2007, Journal of child and adolescent psychopharmacology.

Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

J. Biederman, J. Wernicke, T. Spencer, 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

Effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD: Preliminary findings from a study in progress

K. Loveland, D. Pearson, D. Lachar, 1996 .

Retest stability of DSM-III-R diagnoses among adolescents using the diagnostic interview schedule for children (DISC-2.1C)

R. Roberts, Yuan Chen, C. Casat, 1996, Journal of abnormal child psychology.

Efficacy of olanzapine in social anxiety disorder: a pilot study

J. Davidson, K. Connor, C. Casat, 2002, Journal of psychopharmacology.

Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD.

D. Lane, K. Loveland, D. Pearson, 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.

J. Swanson, C. Conners, J. Elia, 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

The DST in children and adolescents with major depressive disorder.

G. Arana, C. Casat, K. Powell, 1989, The American journal of psychiatry.

Using Behavior Rating Scales forADHD Across Ethnic Groups

R. Reid, H. Norton, A. Anastopoulos, 2001 .

Acute time to response in the Treatment for Adolescents with Depression Study (TADS).

P. Rohde, B. Vitiello, S. McNulty, 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response.

D. Lane, K. Loveland, D. Pearson, 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

Childhood anxiety disorders:: A review of the possible relationship to adult panic disorder and agoraphobia

C. Casat, 1988 .

Identification of elementary school children at risk for disruptive behavioral disturbance: validation of a combined screening method.

H. Norton, C. Casat, M. Boyle-Whitesel, 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

School-Based Mental Health Services (SBS): A Pragmatic View of a Program.

C. Casat, J. Sobolewski, J. Gordon, 1999 .

Serial dexamethasone suppression tests (DST) in recently hospitalized children

H. Rhoades, C. Casat, Debora Pearson, 1994, Biological Psychiatry.

Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial

J. Biederman, J. Wernicke, T. Spencer, 2001, European Neuropsychopharmacology.

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

Allan Reiss, M. Reader, C. Conners, 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

Bupropion in children with attention deficit disorder.

D. H. Schroeder, C. Casat, D. Parler, 1989, Psychopharmacology bulletin.

Methylphenidate effects on a laboratory aggression measure in children with ADHD.

D R Cherek, D. Pearson, D. Cherek, 1995, Psychopharmacology bulletin.